1. Home
  2. PRME vs IDE Comparison

PRME vs IDE Comparison

Compare PRME & IDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRME
  • IDE
  • Stock Information
  • Founded
  • PRME 2019
  • IDE 2010
  • Country
  • PRME United States
  • IDE United States
  • Employees
  • PRME N/A
  • IDE N/A
  • Industry
  • PRME Medicinal Chemicals and Botanical Products
  • IDE Finance/Investors Services
  • Sector
  • PRME Health Care
  • IDE Finance
  • Exchange
  • PRME Nasdaq
  • IDE Nasdaq
  • Market Cap
  • PRME 191.7M
  • IDE 182.9M
  • IPO Year
  • PRME 2022
  • IDE N/A
  • Fundamental
  • Price
  • PRME $3.57
  • IDE $12.25
  • Analyst Decision
  • PRME Buy
  • IDE
  • Analyst Count
  • PRME 6
  • IDE 0
  • Target Price
  • PRME $8.88
  • IDE N/A
  • AVG Volume (30 Days)
  • PRME 4.4M
  • IDE 33.5K
  • Earning Date
  • PRME 08-07-2025
  • IDE 01-01-0001
  • Dividend Yield
  • PRME N/A
  • IDE 8.83%
  • EPS Growth
  • PRME N/A
  • IDE N/A
  • EPS
  • PRME N/A
  • IDE N/A
  • Revenue
  • PRME $4,961,000.00
  • IDE N/A
  • Revenue This Year
  • PRME $126.92
  • IDE N/A
  • Revenue Next Year
  • PRME $87.32
  • IDE N/A
  • P/E Ratio
  • PRME N/A
  • IDE N/A
  • Revenue Growth
  • PRME 739.42
  • IDE N/A
  • 52 Week Low
  • PRME $1.11
  • IDE $8.61
  • 52 Week High
  • PRME $5.17
  • IDE $10.46
  • Technical
  • Relative Strength Index (RSI)
  • PRME 46.93
  • IDE 67.74
  • Support Level
  • PRME $3.35
  • IDE $12.14
  • Resistance Level
  • PRME $3.88
  • IDE $12.30
  • Average True Range (ATR)
  • PRME 0.38
  • IDE 0.10
  • MACD
  • PRME -0.12
  • IDE 0.02
  • Stochastic Oscillator
  • PRME 16.00
  • IDE 91.74

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

Share on Social Networks: